TAGS: Natural/ Organic
Amyris has successfully shipped the first fermentation derived cannabinoid to its partner, LAVVAN. Amyris is also well on its way to the shipment of a second cannabinoid in the first half of 2020.
Amyris' Fermentation Technology
Cannabinoid ingredients are produced with Amyris' fermentation technology platform delivering the quality and high purity at a significantly reduced cost relative to cannabis plant grown and derived ingredients.
The company's technology allows Amyris to scale ingredients that are rarer within the cannabis plant, difficult and extremely expensive to extract in quantity. This is the 10
th unique fermentation molecule Amyris has currently in production.
Additional Cannabinoids in Development
Amyris is one of the market leaders in clean beauty and natural ingredients from fermentation and currently has 22 additional molecules in development with some of the world's leading companies as partners and long-term supply and commercialization agreements to ensure successful market entry.
The company also announced that it has agreed on business terms for a partnership with an Asian pharmaceutical company to develop and scale a breakthrough target for a rare oncology treatment. In addition to the success in cannabinoids and the new opportunity in oncology, the company has also agreed to significantly expand its current collaboration with its Chinese partner for vitamins. Amyris plans to provide further details on these agreements at an investor update meeting to be scheduled in February.
"
We plan to continue building on our position as the leading synthetic biology company by continuing to deliver the highest purity and most sustainably sourced ingredients for the Health, Beauty and Flavor and Fragrance industries,” commented John Melo, president and CEO of Amyris.
“
Our brands are delivering the leading products in their respective categories and this is helping us deliver an excellent quarter. We expect to have our financing needs behind us early in 2020 and a strong year of profitable growth," adds Melo.
Source: Amyris